Proliferation Markers in Different Types of Clinically Non-Secreting Pituitary Adenomas

Pituitary

Volumn 1, Issue 3-4, 1999, Pages 213-220

  Schreiber, Silke ^a   Saeger, Wolfgang ^a,c   Lüdecke, Dieter K ^b  

^a Institute of Pathology of the Marienkrankenhaus Hamburg   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c NONE   (Germany)

Author keywords

Immunohistology; Ki 67; p53; Pituitary adenomas; Proliferation

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; GONADOTROPIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADENOMA; ARTICLE; CELL DIVISION; COMPARATIVE STUDY; HUMAN; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; ONCOCYTOMA; PATHOLOGY; SECRETION;

ADENOMA; ADENOMA, OXYPHILIC; BIOLOGICAL MARKERS; CELL DIVISION; GONADOTROPINS, PITUITARY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033123326     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1009933820856     Document Type: Article

References (35)

1. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, Joubert D. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 1993;77:1125-1129.
2. Asa SL, Kovacs K. Clinically non-functioning human pituitary adenomas. Can J Neurol Sci 1992;19:228-235.
3. Barbareschi M, Iuzzolino P, Penella A, Allegranza A, dalla Palma P, Doglioni C. p53 protein expression in central nervous system neoplasms. J Clin Pathol 1992;45:583-586.
4. Bourhis T, Bosq J, Wilson GD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eshwege F. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer 1994;57:458-462.
5. Brown DC, Gatter KC. Monoclonal antibody Ki 67: Its use in histopathology. Histopathology 1990;17:489-503.
6. Buckley N, Bates AS, Broome J, Strange R, Perrett C, Burke C, Clayton R. p53 protein accumulates in Cushing's adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 1994;79:1513-1516.
7. Carbone DP, Mitsudomi T, Chiba I, Piantadoci S, Rusch V, Nowak JA, Mc Intire D, Slimon D, Gazdar A, Minna J. p53 immunostaining is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: A preliminary report of the LCSG 871. Chest 1994;106:377-381.
8. Gandour-Edwards R, Kapadia SB, Janecka I, Martinez AJ, Barnes L. Biological markers of invasive pituitary adenomas involving the sphenoid sinus. Modern Pathol 1995;8:160-164.
9. Gelsleichter L, Gown A, Zarbo R, Wang E, Coltrera M. p53 and mdm-2 expression in malignant melanoma: An immunhistochemical study of expression of p53, mdm-2 and markers of cell proliferation in primary versus metastatic tumors. Modern Pathol 1995;8:530-535.
10. Harris C, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-1327.
11. Holm R. Null cell adenomas and onocytomas of the pituitary gland. Path Res Pract 1995;191:348-352.
12. Hopf NJ, Brem J, Perneczky A. Image analysis of proliferating cells in tumors of the human nervous system: An immunohistochemical study with the monoclonal antibody Ki-67. Neurosurgery 1994;35:917-923.
13. Hsu DW, Hakim F, Biller BMK, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753-761.
14. Jensen RA, Page DI. p53: The promising story continues to unfold. Hum Pathol 1993;24:455-456.
15. Kawamato H, Uozumi T, Arita K, Yano T, Hirohata T. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas. Acta Neurochir 1995;136:37-43.
16. Kitz K, Knosp E, Koos WT, Korn A. Proliferation in pituitary adenomas: Measurement by MAb Ki-67. Acta Neurochir 1991;53:60-64.
17. Klibanski A. Nonsecreting pituitary tumors. J Clin Endocrinol Metab 1987;16:793-804.
18. Knosp E, Kitz K, Perneczky A. Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67. Neurosurgery 1989;25:927-930.
19. Landoldt A, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg 1987;67:803-806.
20. Landolt AM, Shibata T, Kleihues P, Tuncdogan E. Growth of human pituitary adenomas: Facts and speculations. Advances in the Biosciences 1988;69:53-62.
21. Levine AJ, Chang A, Dittmer D, Notterman DA, Silver A, Thorn K, Welsh D, Wu M. The p53 tumor suppressor gene. J Lab Clin Med 1994;123:817-823.
22. Levine AJ, Perry ME, Chang A, Silver D, Dittmer D, Wu M, Welsh D. The 1993 Walter Hubert Lecture: The role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 1994;69:409-416.
23. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-456.
24. Lüdecke DK, Beck-Bornholdt H-P, Saeger W, Schmidt W Tumour ploidy in DNA histograms of pituitary adenomas. Acta Neurochir 1985;76:18-22.
25. Pernicone P, Scheithauer BW, Sebo T, Kovacs K, Horvath E, Young WF Jr, Ebersold MJ. Pituitary carcinoma: A clinicopathologic study of fifteen cases. J Neuropathol Exp Neurol 1995;54:456.
26. Sano T, Yamada S. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: Special references to gonadotropin-positive adenomas. Pathol Int 1994;44:697-703.
27. Sautner D, Saeger W Invasiveness of pituitary adenomas. Pathol Res Pract 1991;187:632-636.
28. Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of pituitary tumors with special reference to functional classification. J Neurosurg 1986;65:733-744.
29. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling and nucleolar organizer region counts. Acta Neuropathol 1992;84:178-183.
30. Sumi T, Stefaneanu L, Kovacs K, Asa S, Rindi G. Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol 1993;4:95-99.
31. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the mib-1 antibody. Neurosurgery 1996;38:99-107.
32. Thapar K, Scheithauer BW, Kovacs K, Penicone PJ, Laws ER. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996;38:765-771.
33. Tsuzuki T, Tsunoda S, Sakaki T, Konoshi N, Hiasa Y, Nakamura M, Yoshino E. tumor cell proliferation and apoptosis associated with the gamma knife effect. Stereotact Funct Neurosurg 1996;66(suppl 1):39-48.
34. Wang D-C, Johnston CF, Atkinson AB, Heaney AP, Mirakhur M, Buchanan KD. Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc. J Clin Pathol 1996;49:795-797.
35. Yamada S, Asa SL, Kovacs K. Oncocytomas and null cell adenomas of the human pituitary: Morphometric and in vitro fuctional comparison. Virchows Archiv A Pathol Anat 1988; 413:333-339.